Efficacy of liposomal budesonide in experimental asthma

Journal of Allergy and Clinical Immunology

Volumn 111, Issue 2, 2003, Pages 321-327

  Konduri, Kameswari S ^a   Nandedkar, Sandhya ^a   Düzgünes, Nejat ^c   Suzara, Vincent ^c   Artwohl, James ^b   Bunte, Ralph ^b   Gangadharam, Pattisapu R J ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c Division of Allergy and Immunology ^*

Author keywords

Asthma; Budesonide; Inhaled glucocorticoids; Liposomes; Lung inflammation

Indexed keywords

BUDESONIDE; IMMUNOGLOBULIN E; LIPOSOME; OVALBUMIN; PEROXIDASE;

AEROSOL; ALLERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CELL ASSAY; CELL COUNT; CONTROLLED STUDY; DRUG MECHANISM; ENCAPSULATION; ENZYME ACTIVITY; EOSINOPHIL; HISTOPATHOLOGY; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATION; LUNG PARENCHYMA; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; TIME; TOXICITY;

EID: 0037323990     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.104     Document Type: Article

References (35)

1. Weiss KB, Sullivan SD. The health economics of asthma and rhinitis. I. Assessing the economic impact. J Allergy Clin Immunol 2001;107:3-8.
2. US Public Health Service. National Heart, Lung, and Blood Institute. Practical guide for the diagnosis and management of asthma. NIH publication No. 97-4053. Bethesda (MD): The Institute; 1997.
3. Pedersen S, O'Byrne PM. A comparison of the efficacy and safety of inhaled corticosteroids in asthma. Allergy 1997;52:1-34.
4. O'Byrne PM, Pedersen S. Measuring efficacy and safety of different inhaled corticosteroid preparations. J Allergy Clin Immunol 1998;102:879-86.
5. Brown PH, Blundell G, Greening AP, Crompton GK. Screening for hypothalamic'-pitutary-adrenal axis suppression in asthmatics taking high dose inhaled corticosteroids. Respir Med 1991;85:511-6.
6. Wong J, Black P, Acute adrenal insufficiency associated with high dose inhaled steroids. Br Med J 1992;304:1415-6.
7. Toogood JH, Sorva R, Puolijoki H. Review of the effects of inhaled steroids therapy on bone. Int J Risk Safety Med 1994;5:1-14.
8. Bakker-Woudenberg IAJM, Lokerse AF, ten Kate MT, Monton JW, Woodle MC, Storm G. Liposomes with prolonged circulation and selective localization in Klebsiella pneumoniae infected lung tissue. J Infect Dis 1993;168:164-71.
9. Gangadharam PRJ, Ashtekar DR, Flasher D, Düzgünes N. Therapy of Mycobacterium avium complex infection in beige mice with streptomycin encapsulated in sterically stabilized liposomes. Antimicrob Agents Chemother 1995;39:725-30.
10. Düzgünes, N. Treatment of human immunodeficiency virus, Mycobacterium avium, and Mycobacterium tuberculosis infections by liposome-encapsulated drugs. In: Lasic D, Papahadjopoulos D, editors. Medical applications of liposomes. Elsevier Science BV, Amsterdam, 1998; p. 189-219.
11. Wasan KM, Lopez-Berestein G. The development of liposomal amphotericin B: an historical perspective. In: Lasic D, Papahadjopoulos D, editors. Medical applications of liposomes. Amsterdam: Elsevier Science BV; 1998; p. 165-80.
12. Taylor KMG, Taylor G, Kellaway IW, Stevens J. The influence of liposomal encapsulation on sodium cromoglycate pharmacokinetics in man. Pharm Res 1989;6:633-6.
13. Gonda I. Aerosols for delivery of therapeutic and diagnostic agents to the respiratory tract. CRC Crit Rev Therap Drug Carrier Syst 1990;6:272-313.
14. Dijkstra J, Van Galen WJM, Hulstaert CE, Kalicharan D, Roerdink FH, Scherphof GL. Interaction of liposomes with Kupffer cells in vitro. Exp Cell Res 1984;150:161-76.
15. Schreier H, Lukyanov AN, Hochhaus G, Gonzalez-Rothi RJ. Thermodynamic and kinetic aspects of the interaction of triamcinolone acetonide with liposomes. Proc Intl Symp Cont Rel Bioact Mater 1994;21:228-9.
16. Gonzalez-Rothi RJ, Suarez S, Hochhaus G, Schreier H, Lukyanov A, Derendorf H, et al. Pulmonary targeting of liposomal triamcinolone acetonide. Pharm Res 1996;13:1699-703.
17. Farr SJ, Kellaway IW, Carman-Meakin B. Comparison of solute partitioning and efflux of liposomes formed by a conventional and aerosolized method. Int J Pharmaceut 1989;51:39-46.
18. 99technetium-labeled beclomethasone diproprionate dilauroyl-phosphatidylcholine liposome aerosol in normal volunteers. Int J Pharmaceut 1995;115:209-16.
19. Waldrep JC, Gilbert BE, Knight CM, Black BM, Scherer P, Knight V, et al. Pulmonary delivery of beclomethasone liposome aerosol in volunteers. Chest 1997;111:316-23.
20. Waldrep JC, Keyhani K, Black M, Knight V. Operating characteristics of 18 different continuous-flow jet nebulizers with beclomethasone dipropionate liposome aerosol. Chest 1994;105:106-10.
21. Gabizon A, Papahadjopoulos D. Liposome formulatious with prolonged circulation time in blood and enhanced uptake by tumors. Proc Natl Acad Sci 1988;85:6949-53.
22. Allen TM, Hansen C, Martin F, Redemann C, Yau-Young A. Liposomes containing synthetic lipid derivatives of poly (ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta 1991:1066:29-36.
23. Taylor KMG, Taylor G, Kellaway IW, Stevens J. The stability of liposome nebulization. Int J Pharmaceut 1990;58:57-61.
24. Huang SK, Martin FJ, Friend DS, Papahadjopoulos D. Mechanism of stealth liposome accumulation in some pathological tissues. In: Lasic D, Martin F editors. Stealth liposomes, Boca raton (FL): CRC Press; 1995; p. 119-25.
25. Busse WW, Lemanske RF Jr. Asthma. N Engl J Med 2001;344:350-62.
26. Vignola AM, Chanez P, Campbell AM, Souques F, Lebel B, Enander I, et al. Airway inflammation in mild intermittent and in persistent asthma. Am J Respir Crit Care Med 1998;157:403-9.
27. De Siqueria ALP, Russo M, Stell AA, Facincone S, Mariano M, Jancar S. A new murine model of pulmonary eosinophilic hypersensitivity: contribution to experimental asthma. J Allergy Clin Immunol 1997;100:383-8.
28. Nandedkar SD, Konduri KS, Artwohl J, Bunte R, Gangadharam PRJ. A novel approach to ovalbumin sensitization in C57b1/6 mice [abstract 580]. J Allergy Clin Immunol 2001;107:S176.
29. Strath M, Warren DJ, Sanderson CJ. Detection of eosinophils using an eosinophil peroxidase assay. Its use as an assay for eosinophil differentiation factors. J Immunol Methods 1985;83:209-15.
30. Mayer LB, Cullis PR, Bally MB. Designing therapeutically optimized liposomal anticancer delivery systems: lessons from conventional liposomes. In: Lasie D, Papahadjopoulos D, editors. Medical applications of liposomes. Amsterdam: Elsevier Science BV; 1998; p. 242-4.
31. Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavamian N, Enander I, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-9.
32. Broide DH, Gleich GJ, Cuomo AJ, Coburn DA, Federman EC, Schwartz LB, et al. Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. J Allergy Clin Immunol 1991;88:637-48.
33. Woolley MJ, Denburg JA, Ellis R, Dahlback M, O'Byrne PM. Allergen-induced changes in bone marrow progenitors and airway responsiveness in dogs and the effect of inhaled budesonide on these parameters. Am J Respir Cell Mol Biol 1994;11:600-6.
34. Lonnkvist K, Hellman C, Lundahl J, Hallden G, Hedlin G. Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal. J Allergy Clin Immunol 2001;107:812-7.
35. Wardlaw AI, Kay AB. The role of the eosinophil in the pathogenesis of asthma. Allergy 1987;42:321-35.